Growth Metrics

Conmed (CNMD) Free Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -74.34%
Dec 31, 2025 -15.00%
Sep 30, 2025 107.22%
Jun 30, 2025 -38.01%
Mar 31, 2025 -3.93%
Dec 31, 2024 -17.76%
Sep 30, 2024 20.31%
Jun 30, 2024 46.63%
Mar 31, 2024 -47.45%
Dec 31, 2023 26.53%
Sep 30, 2023 83.95%
Jun 30, 2023 373.35%
Mar 31, 2023 53.10%
Dec 31, 2022 -190.05%
Sep 30, 2022 47.20%
Jun 30, 2022 487.94%
Mar 31, 2022 -110.98%
Dec 31, 2021 93.81%
Sep 30, 2021 -49.54%
Jun 30, 2021 62.65%
Mar 31, 2021 13.17%
Dec 31, 2020 -46.62%
Sep 30, 2020 1,681.70%
Jun 30, 2020 99.44%
Mar 31, 2020 -97.42%
Dec 31, 2019 9.31%
Sep 30, 2019 91.23%
Jun 30, 2019 308.93%
Mar 31, 2019 -139.82%
Dec 31, 2018 18,400.00%
Sep 30, 2018 -100.64%
Jun 30, 2018 -19.41%
Mar 31, 2018 23.47%
Dec 31, 2017 76.96%
Sep 30, 2017 -25.72%
Jun 30, 2017 2.93%
Mar 31, 2017 35.60%
Dec 31, 2016 -57.37%
Sep 30, 2016 67.81%
Jun 30, 2016 167.74%
Mar 31, 2016 -323.25%
Dec 31, 2015 -13.08%
Sep 30, 2015 52.82%
Jun 30, 2015 -39.30%
Mar 31, 2015 -52.20%
Dec 31, 2014 104.29%
Sep 30, 2014 232.34%
Jun 30, 2014 -74.44%
Mar 31, 2014 -42.19%
Dec 31, 2013 -10.80%
Sep 30, 2013 84.65%
Jun 30, 2013 914.23%
Mar 31, 2013 -95.27%
Dec 31, 2012 20.16%
Sep 30, 2012 15.32%
Jun 30, 2012 1,599.25%
Mar 31, 2012 -94.37%
Dec 31, 2011 -33.92%
Sep 30, 2011 114.65%
Jun 30, 2011 -8.86%
Mar 31, 2011 -13.21%
Dec 31, 2010 331.20%